Adding GLP-1 RA to SGLT2i Reduces Mortality and Hospitalization in Heart Failure and ASCVD Patients: Study Medha Baranwal4 March 2025 8:00 AM ISTTaiwan: A recent cohort study has highlighted the potential benefits of combining glucagon-like peptide-1 receptor agonists (GLP-1 RAs) with...
Novel subcutaneous furosemide therapy safe and feasible for home-based care for patients with HF Dr. Kamal Kant Kohli4 Nov 2023 11:45 AM ISTThe FDA has approved furosemide as a treatment for managing conditions characterized by excess volume and oedema resulting from congestive heart...
Bempedoic acid effective in reducing MI risk among statin-intolerant patients with hyperlipidemia Dr. Kamal Kant Kohli7 Aug 2023 11:00 AM ISTAustria: A recent review published in European Heart Journal - Cardiovascular Pharmacotherapy has shed light on cardiovascular (CV) events in patients...
Even Low dose diclofenac not risk neutral for cardiovascular events Dr. Shravani Dali8 April 2023 11:30 AM ISTEven Low dose diclofenac is not risk neutral for cardiovascular events suggests a new study published in the European Heart Journal - Cardiovascular...
Spironolactone has beneficial BP lowering effect in patients with heart failure risk Dr. Nandita Mohan12 May 2021 6:30 AM ISTAccording to recent research published in the European Heart Journal - Cardiovascular Pharmacotherapy, researchers have found out that...
